US FDA approves Pfizer & Astellas’ Padcev plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility: New York Monday, July 13, 2026, 13:00 ...
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ...
The platinum-free combination significantly improved EFS, OS, and pathologic complete response rates compared with standard neoadjuvant gemcitabine/cisplatin.
MUSC names CEO comprehensive cancer hospital to lead $1.1B project, overseeing design, operations, and integration in Charleston by 2030.
Cancer ChristianaCare Graham Center joins the Association of American Cancer Institutes, enhancing research and patient care collaboration.
According to DKMS, the world's largest blood stem cell donor center, 70% of patients must rely on donors outside their ...
New results from an Alliance Foundation Trials (AFT) study reveal that a simple weekly electronic symptom check-in with care team, significantly improves the quality of life for individuals undergoing ...
A new study from University Hospitals Connor Whole Health reports that an insurance-supported integrative oncology program ...
Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict ...
A 10-year-old girl celebrated the end of a two-year-long battle with leukemia, ringing the bell at a Duke basketball game as both teams united to cheer her on. NBC News’ José Díaz-Balart has more on ...
RALEIGH — No. 1 Duke just keeps rolling. And NC State needs to find a way to steady itself. Other WRAL Top Stories The visiting Blue Devils outclassed the Wolfpack 93-64 on Monday night at Lenovo ...
FOX 26 Houston on MSN
Duke MBA student with leukemia seeks blood stem cell donor as minority patients face lower match rates
Doctors told Chizoma Ekechukwu something no one wants to hear. She has leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results